Table 2.

Proportion of responders who showed symptomatic improvement after treatment (primary outcome measure).

	Alkaline-reduced water group (n = 13)	Control group (n = 14)	p value
Responder, n (%)	8 (61.5%)	6 (42.9%)	0.449
Nonresponder, n (%)	5 (38.5%)	8 (57.1%)